Search research articles
Contact Us
Filters
Showing results (201-210 of 224) with videos related to
Page
of 23
Sort By:
Cancer Discovery
|
September 14, 2017
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles
Vito W Rebecca, Michael C Nicastri, Noel McLaughlin, et al.
Journal of Hepatology
|
April 28, 2016
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer
Beatrice Bissig-Choisat, Claudia Kettlun-Leyton, Xavier D Legras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
Shengnan Yu, Shiyou Wei, Milan Savani, et al.
Nature
|
August 10, 2018
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen, Alexander C Huang, Wei Zhang, et al.
Nature Communications
|
July 9, 2022
Multi-modal molecular programs regulate melanoma cell state
Miles C Andrews, Junna Oba, Chang-Jiun Wu, et al.
Nature
|
December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Science Advances
|
February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncology
Jun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Cancer Cell
|
July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer
Krishna M Vasudevan, David A Barbie, Michael A Davies, et al.
The Journal of Clinical Investigation
|
April 5, 2016
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Gao Zhang, Dennie T Frederick, Lawrence Wu, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 224) with videos related to
Sort By:
Page
of 23
Cancer Discovery
|
September 14, 2017
A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles
Vito W Rebecca, Michael C Nicastri, Noel McLaughlin, et al.
Journal of Hepatology
|
April 28, 2016
Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer
Beatrice Bissig-Choisat, Claudia Kettlun-Leyton, Xavier D Legras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
Shengnan Yu, Shiyou Wei, Milan Savani, et al.
Nature
|
August 10, 2018
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen, Alexander C Huang, Wei Zhang, et al.
Nature Communications
|
July 9, 2022
Multi-modal molecular programs regulate melanoma cell state
Miles C Andrews, Junna Oba, Chang-Jiun Wu, et al.
Nature
|
December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Science Advances
|
February 9, 2022
A functional genomic approach to actionable gene fusions for precision oncology
Jun Li, Hengyu Lu, Patrick Kwok-Shing Ng, et al.
Cancer Cell
|
July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer
Krishna M Vasudevan, David A Barbie, Michael A Davies, et al.
The Journal of Clinical Investigation
|
April 5, 2016
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Gao Zhang, Dennie T Frederick, Lawrence Wu, et al.
Page
of 23